Blaze Bioscience, Inc. (Blaze)

Oncology Corporate Profile

HQ Location

530 Fairview Avenue North, Suite 1400
Seattle, WA 98109

Company Description

Blaze Bioscience is dedicated to developing products that assist physicians in their quest to improve the lives of cancer patients. Blaze was co-founded by Dr. Jim Olson of Fred Hutchinson Cancer Research Center and Heather Franklin, a former senior business executive at ZymoGenetics, Inc., to develop and commercialize Tumor Paint technology. Tumor Paint technology is designed to provide real-time, high-resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical removal of cancer, and has potential applications in a broad array of solid tumor cancers.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BLZ-101targeting peptide + flourescent dyeBrain cancerI
BLZ-100targeting peptide + flourescent dyeMelanomaI
BLZ-101targeting peptide + flourescent dyeSarcomaI
BLZ-101targeting peptide + flourescent dyeBreast cancerPreclinical
BLZ-101targeting peptide + flourescent dyeColorectal cancerPreclinical
BLZ-101targeting peptide + flourescent dyeNon Small Cell Lung Cancer (NSCLC)Preclinical
BLZ-101targeting peptide + flourescent dyeProstate cancerPreclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display